Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Clinical Gastroenterology|December 1, 1987
Postoperative jaundice as a clue to unrecognized biliary tract obstructionA Kartsonis, K R Reddy, H D Manten, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 8, 2008
Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infectionsM J Dinubile, K M Strohmaier, R J Lupinacci, et al.
Vaccine|December 24, 2011
The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studiesClayton D Harro, Robert F Betts, Jonathan S Hartzel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 12, 2012
A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosisS Kohno, K Izumikawa, M Yoshida, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin databaseArnaldo L Colombo, Angela L Ngai, Michael Bourque, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infectionsMatthew Sims, Valeri Mariyanovski, Patrick McLeroth, et al.
The American Journal of Medicine|October 4, 2002
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasisAlvaro Villanueva, Eduardo Gotuzzo, Eduardo G Arathoon, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Population pharmacokinetics and pharmacodynamics of caspofungin in pediatric patientsChi-Chung Li, Peng Sun, Yingwen Dong, et al.
The Pediatric Infectious Disease Journal|February 7, 2018
Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal BacteremiaAntonio C Arrieta, John S Bradley, Myra W Popejoy, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal InfectionChristopher Lucasti, Liviu Vasile, Dorel Sandesc, et al.
Pageof 4